Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer

J. Kaneti, Y. Winikoff, S. Zimlichman, R. Shainkin-Kestenbaum

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Serum amyloid A (SAA) and acid phosphatase (AcP) levels were determined in serial serum samples of 35 patients in different stages of dissemination and correlated with activity of carcinoma of the prostate. Up to 500-fold increases in SAA level were detected during active periods of cancer with a decrease towards the normal range in remission, in comparison with a 10-fold increase of AcP. The correlation between these two parameters was highly significant (P<0.001), but while SAA shows 100% sensivity during the active stage, AcP shows only 85% sensitivity. It is suggested that althouth SAA is not a specific marker for any particular illness, due to its characteristic pattern of change in malignant diseases and its high sensitivity, it represents a useful biochemical parameter for the assessment of the activity of the disease to monitor response to therapy during follow-up.

Original languageEnglish
Pages (from-to)239-241
Number of pages3
JournalUrological Research
Volume12
Issue number5
DOIs
StatePublished - 1 Oct 1984
Externally publishedYes

Keywords

  • Acid phosphatase (AcP)
  • Prostate cancer
  • Serum amyloid A (SAA)

Fingerprint

Dive into the research topics of 'Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer'. Together they form a unique fingerprint.

Cite this